Attached files

file filename
EX-99.1 - AUDITED FINANCIAL STATEMENTS - Cosmos Holdings Inc.cosm_991.htm
8-K/A - FORM 8-K/A - Cosmos Holdings Inc.cosm_8ka.htm

EXHIBIT 99.2

  

Unaudited pro forma combined condensed financial information

 

On February 10, 2017, Cosmos Holdings, Inc (“Cosmos” or the “Company”) closed an Acquisition Agreement pursuant to which the Company acquired Decahedron Ltd. (“Decahedron”) a United Kingdom Company, a pharmaceuticals wholesaler which specializes in imports and exports of branded and generic pharmaceutical products within the EEA and around the world. At closing, the Company acquired 100% of Decahedron’s outstanding shares in exchange for 1,700,000 shares of Cosmos common stock valued at $1,479,000 (the "Acquisition").

 

Basis of Presentation

 

The unaudited pro forma condensed combined financial information was prepared using the acquisition method of accounting and was based on the historical financial information of the Company and Decahedron. The acquisition method of accounting, based on ASC 805, uses the fair value concepts defined in ASC 820, “Fair Value Measurement” (“ASC 820”). The historical consolidated financial information of the Company has been adjusted in the accompanying unaudited pro forma condensed combined financial information to give effect to pro forma events that are (i) directly attributable to the acquisition, (ii) factually supportable, and (iii) with respect to the unaudited pro forma condensed combined statements of operations, expected to have a continuing impact on the consolidated results.

 

The accompanying unaudited pro forma combined statements of operations for year ended December 31, 2016 are presented as if the acquisition of Decahedron had occurred on January 1, 2016.

 

These unaudited pro forma consolidated statements should be read in connection with (1) the Company’s audited consolidated financial statements for the year ended December 31, 2016 and notes thereto filed with the U.S. Securities and Exchange Commission, and (2) the audited financial statements for Decahedron for the years ended December 31, 2016 and 2015 and notes thereto included in Exhibit 99.1 to this Current Report on Form 8-K/A.

 

The unaudited pro forma combined financial information is presented for informational purposes only and is not intended to represent the consolidated financial position or consolidated results of operations of Cosmos that would have been reported had the Acquisition been completed as of the dates described above, and should not be taken as indicative of any future consolidated financial position or consolidated results of operations. The Unaudited Pro Forma Combined Income Statements do not reflect any sales or cost savings from synergies that may be achieved with respect to the combined companies, or the impact of non-recurring items, including restructuring liabilities, directly related to the Acquisition.

 

 
1
 
 

   

COSMOS HOLDINGS, INC.

UNAUDITED PROFORMA COMBINED BALANCE SHEETS

FOR THE YEAR ENDED DECEMBER 31, 2016

 

 

 

10-K Historical

 

 

 

 

 

 

 

 

 

 

 

Cosmos Holdings, Inc.

 

 

Decahedron Limited

(in £GBP)

 

 

Decahedron Limited

(in $USD)

 

 

Pro Forma Adjustments

 

 

Notes

 

Pro Forma Combined

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$ 716,590

 

 

£ 11,618

 

 

$ 14,328

 

 

 

 

 

 

 

$ 730,918

 

Accounts receivable

 

 

661,850

 

 

 

12,905

 

 

 

15,914

 

 

 

 

 

 

 

 

677,764

 

Other receivable

 

 

131,900

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

131,900

 

Inventory

 

 

464,219

 

 

 

49,852

 

 

 

61,478

 

 

 

 

 

 

 

 

525,697

 

Prepaid expenses and other current assets

 

 

646,530

 

 

 

8,029

 

 

 

9,902

 

 

 

 

 

 

 

 

656,432

 

Prepaid expenses and other current assets - related party

 

 

15,523

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

15,523

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL CURRENT ASSETS

 

 

2,636,612

 

 

 

82,404

 

 

 

101,622

 

 

 

 

 

 

 

 

2,738,234

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets

 

 

429,203

 

 

 

57,723

 

 

 

71,185

 

 

 

 

 

 

 

 

500,388

 

Property and equipment, net

 

 

52,715

 

 

 

13,634

 

 

 

16,813

 

 

 

 

 

 

 

 

69,528

 

Intangibles, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

40,000

 

 

(A) (B)

 

 

40,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$ 3,118,530

 

 

£ 153,761

 

 

$ 189,620

 

 

 

 

 

 

 

 

$ 3,348,150

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$ 577,932

 

 

£ 215,505

 

 

$ 265,763

 

 

 

 

 

 

 

 

$ 843,695

 

Accounts payable and accrued expenses - related party

 

 

13,759

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

13,759

 

Notes payable, net of discount of $59,325 and $0, respectively

 

 

2,872,472

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

2,872,472

 

Notes payable - related party

 

 

160,391

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

160,391

 

Loans payable

 

 

17,938

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

17,938

 

Loans payable - related party

 

 

148,250

 

 

 

343,035

 

 

 

423,035

 

 

 

 

 

 

 

 

 

571,285

 

Taxes payable

 

 

1,080,590

 

 

 

(19,761 )

 

 

(24,369 )

 

 

 

 

 

 

 

 

1,056,221

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL CURRENT LIABILITIES

 

 

4,871,332

 

 

 

538,779

 

 

 

664,429

 

 

 

 

 

 

 

 

 

5,535,761

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

4,871,332

 

 

 

538,779

 

 

 

664,429

 

 

 

 

 

 

 

 

 

5,535,761

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIT:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value; 100,000,000 shares authorized; 0 shares issued and outstanding as of December 31, 2016

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

-

 

Common stock, $0.001 par value; 300,000,000 shares authorized; 125,870,532 shares issued and outstanding as of December 31, 2016

 

 

125,871

 

 

 

961

 

 

 

1,185

 

 

 

515

 

 

(D)

 

 

127,571

 

Additional paid-in capital

 

 

174,009

 

 

 

140,000

 

 

 

172,649

 

 

 

1,322,724

 

 

(D)

 

 

1,669,382

 

Accumulated other comprehensive loss

 

 

(1,050,463 )

 

 

-

 

 

 

21,456

 

 

 

(21,456 )

 

(D)

 

 

(1,050,463 )

Accumulated deficit

 

 

(1,002,219 )

 

 

(525,979 )

 

 

(670,099 )

 

 

(1,261,783 )

 

(B) (C) (D)

 

 

(2,934,101 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL STOCKHOLDERS' DEFICIT

 

 

(1,752,802 )

 

 

(385,018 )

 

 

(474,809 )

 

 

 

 

 

 

 

 

(2,187,611 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

 

$ 3,118,530

 

 

£ 153,761

 

 

$ 189,620

 

 

 

 

 

 

 

 

$ 3,348,150

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 
2
 
 

   

UNAUDITED PROFORMA COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2016

 

 

 

 

 

 

 

 

 

10-K Historical

 

 

 

 

 

 

 

 

 

 

 

Cosmos Holdings, Inc. as Reported

 

 

Decahedron Limited in US GAAP

(in £GBP)

 

 

Decahedron Limited in US GAAP

(in $USD)

 

 

Pro Forma Adjustments

 

 

Notes

 

Pro Forma Combined

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$ 6,755,436

 

 

£ 1,476,456

 

 

$ 2,001,336

 

 

 

 

 

 

 

$ 8,756,772

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COST OF REVENUE

 

 

6,154,396

 

 

 

1,456,114

 

 

 

1,973,763

 

 

 

 

 

 

 

 

8,128,159

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

 

601,040

 

 

 

20,342

 

 

 

27,573

 

 

 

 

 

 

 

 

628,613

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

794,099

 

 

 

135,132

 

 

 

183,172

 

 

 

 

 

 

 

 

977,271

 

Depreciation expense

 

 

9,448

 

 

 

3,823

 

 

 

5,182

 

 

 

 

 

 

 

 

14,630

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10,000

 

 

(A)

 

 

10,000

 

TOTAL OPERATING EXPENSES

 

 

803,547

 

 

 

138,955

 

 

 

188,354

 

 

 

 

 

 

 

 

 

1,001,901

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOSS FROM OPERATIONS

 

 

(202,507 )

 

 

(118,613 )

 

 

(160,781 )

 

 

 

 

 

 

 

 

(373,288 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Income

 

 

-

 

 

 

6,507

 

 

 

8,820

 

 

 

 

 

 

 

 

 

8,820

 

Other income

 

 

19

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

19

 

Interest expense - related party

 

 

(264 )

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

(264 )

Interest expense

 

 

(205,750 )

 

 

(168 )

 

 

(228 )

 

 

 

 

 

 

 

 

(205,978 )

Impairment of goodwill

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,921,882 )

 

(B)

 

 

(1,921,882 )

Other expense

 

 

(12,764 )

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

(12,764 )

Foreign currency transaction loss

 

 

(178,967 )

 

 

(86,469 )

 

 

(117,209 )

 

 

 

 

 

 

 

 

(296,176 )

TOTAL OTHER INCOME (EXPENSE)

 

 

(397,726 )

 

 

(80,130 )

 

 

(108,617 )

 

 

 

 

 

 

 

 

(2,428,225 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOSS BEFORE INCOME TAXES

 

 

(600,233 )

 

 

(198,743 )

 

 

(269,398 )

 

 

 

 

 

 

 

 

(2,801,513 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME TAX BENEFIT (EXPENSE)

 

 

(769 )

 

 

23,292

 

 

 

31,572

 

 

 

 

 

 

 

 

 

30,803

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS (LOSS)

 

 

(601,002 )

 

 

(175,451 )

 

 

(237,826 )

 

 

 

 

 

 

 

 

(2,770,710 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER COMPREHENSIVE LOSS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation (loss) gain

 

 

55,215

 

 

 

-

 

 

 

(53,275 )

 

 

 

 

 

 

 

 

1,940

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL OTHER COMPREHENSIVE LOSS

 

£

545,787

 

 

£

175,451

 

 

£

291,101

 

 

 

 

 

 

 

 

$ (2,768,770 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BASIC NET (LOSS) INCOME PER SHARE

 

 

(0.00 )

 

 

(0.00 )

 

 

(0.00 )

 

 

 

 

 

 

 

 

(0.00 )

DILUTED NET (LOSS) INCOME PER SHARE

 

 

(0.00 )

 

 

(0.00 )

 

 

(0.00 )

 

 

 

 

 

 

 

 

(0.00 )

BASIC WEIGHTED AVERAGE SHARES OUTSTANDING

 

 

125,648,237

 

 

 

 

 

 

 

 

 

 

 

983,529

 

 

 

 

 

126,631,766

 

DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING

 

 

125,648,237

 

 

 

 

 

 

 

 

 

 

 

983,529

 

 

 

 

 

126,631,766

 

 

The accompanying notes are an integral part of these consolidated financial statements.

  

 
3
 
 

 

Cosmos Holdings Inc. and

Decahedron, Ltd.

Notes to the unaudited pro forma combined financial information

  

1. Basis of pro forma presentation

 

The accompanying unaudited pro forma combined financial information is derived from the historical financial statements of Cosmos and Decahedron. The unaudited pro forma combined financial information is prepared using the purchase method of accounting, as defined by Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 805, Business Combinations, with Cosmos treated as the acquirer.

 

Cosmos, a registrant with a year that ends on December 31, acquired Decahedron with a year that ends on December 31. The pro forma statement of operations for the period ended December 31, 2016 includes (1) Cosmos’s twelve months ended December 31, 2016, and (2) Decahedron’s twelve months ended December 31, 2016.  Unaudited pro forma adjustments and the assumptions on which they are based, are described in the accompanying notes to the unaudited pro forma combined financial statement.

 

The unaudited pro forma combined balance sheet as of December 31, 2016 is presented as if the Acquisition and the borrowings used to finance the Acquisition occurred on January 1, 2016. The unaudited pro forma combined statement of operations for the period ended December 31, 2016 is presented as if the Acquisition occurred on January 1, 2016.

 

The unaudited pro forma combined financial information has been compiled in a manner consistent with the accounting policies adopted by Cosmos. These accounting policies are similar in most material respects to those of Decahedron’s. Cosmos is currently performing a more detailed review of Decahedrons’s accounting policies. As a result of that review, differences could be identified between the accounting policies of the two companies that, when conformed, could have a material impact on the combined financial statements.

 

ASC 820 defines fair value, establishes the framework for measuring fair value for any asset acquired or liability assumed under U.S. GAAP, expands disclosures about fair value measurements and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measures. Fair value is defined in ASC 820 as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date”. This is an exit price concept for the valuation of an asset or liability. Market participants are assumed to be buyers or sellers in the most advantageous market for the asset or liability. Fair value measurement for an asset assumes the highest and best use by these market participants, and as a result, assets may be required to be recorded which are not intended to be used or sold and/or assets may be required to be valued at a fair value measurement that does not reflect management’s intended use for those assets. Fair value measurements can be highly subjective and it is possible that the application of reasonable judgment could result in different assumptions and a range of alternative estimates using the same facts and circumstances.

 

The unaudited pro forma combined financial information is presented for informational purposes only and is not intended to represent the consolidated financial position or consolidated results of operations of Cosmos that would have been reported had the Acquisition been completed as of the dates described above, and should not be taken as indicative of any future consolidated financial position or consolidated results of operations. The unaudited pro forma combined statement of operations does not reflect any sales or cost savings from synergies that may be achieved with respect to the combined companies, or the impact of non-recurring items, including restructuring liabilities, directly related to the Acquisition.

 

The unaudited pro forma combined financial information should be read in conjunction with the historical consolidated financial statements and accompanying notes of Cosmos and Decahedron.

 

 
4
 
 

 

2. Purchase price

 

The Acquisition closed on February 10, 2017.

 

The net purchase price of Decahedron was determined to be as follows:

 

 

 

Stock Price at Closing

 

 

Shares

 

 

Fair Value

 

Purchase price:

 

 

 

 

 

 

 

 

 

Common Stock at closing

 

$ 0.87

 

 

 

1,700,000

 

 

$ 1,479,000

 

Less: Adjusted Net Assets

 

 

 

 

 

 

 

 

 

$ (492,882 )

Net purchase price

 

 

 

 

 

 

 

 

 

$ 1,971,882

 

 

The preliminary purchase price allocation of Decahedron was determined to be as follows:

 

Purchase price allocation:

 

 

 

 

 

 

Other Intangibles (License)

 

 

 

 

 

50,000

 

Goodwill

 

 

 

 

 

1,921,882

 

Total Purchase Price

 

 

 

 

$ 1,971,882

 

 

3. Pro Forma Adjustments

 

Certain reclassifications have been made to conform Decahedron’s historical amounts to Cosmos’s financial statement presentation. The accompanying unaudited pro forma combined statement of operations for the year ended December 31, 2016 have been prepared to reflect the acquisition of Decahedron by Cosmos for an aggregate purchase price of $1,479,000 as if the acquisition was completed on January 1, 2016 for Statement of Operations purposes and reflect the following pro forma adjustments:

 

(A) To record preliminary fair values of the intangible assets acquired in connection with the Decahedron acquisition and to allocate the purchase consideration to finite lived intangible assets and the excess of the purchase consideration over the fair value of assets acquired to goodwill. The net assets of Decahedron at December 31, 2016 were $ 23,563. The intangible assets were valued at $50,000 for the fair market value of the United Kingdom import/export license for wholesale pharmaceuticals with the remainder allocated to Goodwill in the amount of $ 1,398,679.

 

 

(B) To record a full year of amortization on the intangible assets.

 

 

(C) To record impairment of goodwill that was recorded as a result of the Decahedron acquisition and the excess of the purchase consideration over the fair value of assets acquired and its full impairment for the acquisition of Decahedron for the period ended December 31, 2016 as if the acquisition was completed on January 1, 2016.

 

 

(D) To reflect the elimination of the Company’s investment in Decahedron related to amounts the Company has already paid the seller pursuant to its acquisition.

  

 
5
 
 

 

To supplement the consolidated financial results prepared under generally accepted accounting principles (“GAAP”), the Company uses a pro forma measure of net income or loss that consists of GAAP net income or loss adjusted to exclude the impact of amortization of acquisition-related charges and other non-recurring charges and gains.

 

Pro forma net income gives an indication of the Company’s baseline performance before gains, losses or other charges that are considered by management to be outside of our core operating results. In addition, pro forma net income is among the primary indicators management uses as a basis for planning and forecasting future periods. These measures are not in accordance with or an alternative for GAAP and may be materially different from pro forma non-GAAP measures used by other companies.

 

4. Accounting Policies

 

Acquisition accounting rules require evaluation of certain assumptions and estimates, as well as determination of financial statement classifications which are completed during the measurement period as defined in current accounting standards. Adjustments were made to translate the financial statements of Decaheadron from British Pound Sterling into U.S. dollars, as set out further in Note 5. During the preparation of this unaudited pro forma condensed combined financial information, management performed a preliminary analysis of Decahedron’s accounting policies. Accordingly, this unaudited pro forma condensed combined financial information assumes no material differences in accounting policies between the two companies. Management will conduct a final review of Decahedron’s accounting policies in an effort to determine if differences in accounting policies require adjustment or reclassification of Decahedron’s results of operations or require reclassification of assets or liabilities to conform to the Company’s accounting policies and classifications, or other adjustments which may be required by acquisition accounting rules. As a result of that review, management may identify differences that, when conformed, could have a material impact on this unaudited pro forma condensed combined financial information.

 

5. Reconciliation to U.S. GAAP of Decahedron’s Historical Financial Information:

 

Decahedron’s historical financial statements have been prepared in accordance with U.K. GAAP.  Adjustments have been made to align Decahedron’s historical financial statements with the Company’s U.S. GAAP accounting policies. These adjustments represent the Company’s best estimates based upon available information.

 

Decahedron’s financial information reflected in the pro forma financial information has been translated from British Pounds Sterling into U.S. dollars using the following historical exchange rates: 

 

December 31, 2016 Average:

 

 

1.3555

 

December 31, 2016 Spot:

 

 

1.2332

 

 

 
6
 
 

 

Unaudited Pro Forma Decahedron Statement of Operations for the Year Ended December 31, 2016

 

The following table reflects the adjustments made to the Decahedron’s statement of operations for the year ended December 31, 2016 to translate from British Pound Sterling to U.S. Dollars using a historical average exchange rate of £ 1.3555 to $1.00 from January 1, 2016, to December 31, 2016.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Decadhedron in U.K. GAAP

(in £GBP)

 

 

U.S. GAAP Adjustments

(in £GBP)

 

 

Decahedron in U.S. GAAP

(in £GBP)

 

 

Decahedron in U.S. GAAP

(in $ USD)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (Turnover)

 

£ 1,900,656

 

 

 

(424,200 )(a)

 

£ 1,476,456

 

 

$ 2,001,336

 

Cost of sales

 

 

1,456,114

 

 

 

-

 

 

 

1,456,114

 

 

 

1,973,763

 

Gross profit

 

 

444,542

 

 

 

(424,200 )

 

 

20,342

 

 

 

27,573

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

220,395

 

 

 

(85,263 )(a)(b)(c)

 

 

135,132

 

 

 

183,172

 

Depreciation expense

 

 

3,823

 

 

 

-

 

 

 

3,823

 

 

 

5,182

 

Income (Loss) from Operations

 

 

220,324

 

 

 

(338,937 )

 

 

(118,613 )

 

 

(160,781 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

-

 

 

 

6,507 (b)

 

 

6,507

 

 

 

8,820

 

Interest expense

 

 

(168 )

 

 

-

 

 

 

(168 )

 

 

(228 )

Foreign currency transaction loss

 

 

-

 

 

 

(86,469 )(c)

 

 

(86,469 )

 

 

(117,209 )

Income tax benefit (expense)

 

 

23,292

 

 

 

-

 

 

 

23,292

 

 

 

31,572

 

Income (loss) from continuing operations

 

£ 243,448

 

 

£ 418,899

 

 

£ 175,451

 

 

$ (237,826 )

____________

(a)

For reporting entities, U.S. GAAP for publicly held companies sets forth four requirements that must generally be met before revenue can be realized and earned: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services have been rendered; (3) the seller’s price to the buyer is fixed or determinable; and (4) collectability is reasonably assured. At the time of this filing, Decadhedron Net Sales (Turnover) includes income for research services with a related party, the collection of which has not been received and cannot be reasonable assured. Therefore, these sales (£424,200) have been excluded and the related foreign currency loss (£5,302).

(b)

For reporting entities, U.S. GAAP requires the disclosure of interest income to be reported seperately.

(c)

For reporting entities, U.S. GAAP requires the disclosure of foreign currency transaction loss to be reported seperately.

 

 
7
 
 

 

Unaudited Pro Forma Decahedron Balance Sheet as of December 31, 2016

 

The following table reflects the adjustments made to Decahedron’s balance sheet as of December 31, 2015, to translate from British Pound Sterling to U.S. Dollars using the spot rate of £ 1.2332 to $1.00 as of December 31, 2016.

 

 

 

Decadhedron

in U.K. GAAP

(in £GBP)

 

 

U.S. GAAP Adjustments

(in £GBP)

 

 

Decahedron

in U.S. GAAP

(in £GBP)

 

 

Decahedron

in U.S. GAAP

(in $ USD)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

£ 11,619

 

 

£ -

 

 

£ 11,619

 

 

$ 14,328

 

Debtors: amounts falling due within one year

 

 

666,266

 

 

 

(666,266 )(b)

 

 

-

 

 

 

-

 

Accounts receivable

 

 

-

 

 

 

12,905 (b)

 

 

12,905

 

 

 

15,914

 

Prepaid expenses and other current assets

 

 

-

 

 

 

8,029 (b)

 

 

8,029

 

 

 

9,902

 

Inventory

 

 

49,852

 

 

 

-

 

 

 

49,852

 

 

 

61,478

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL CURRENT ASSETS

 

 

727,737

 

 

 

(645,332 )

 

 

82,405

 

 

 

101,622

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other assets

 

 

-

 

 

 

57,723 (b)

 

 

57,723

 

 

 

71,185

 

Property and equipment, net

 

 

13,635

 

 

 

-

 

 

 

13,635

 

 

 

16,813

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

£ 741,372

 

 

£

587,609

 

 

£ 153,763

 

 

$ 189,620

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

£ -

 

 

£ 215,506

 

 

£ 215,506

 

 

$ 265,763

 

Creditors: amounts falling due within one year

 

 

707,492

 

 

 

(707,492 )(b)

 

 

-

 

 

 

-

 

Loans payable - related party

 

 

-

 

 

 

343,036 (b)

 

 

343,036

 

 

 

423,035

 

Taxes payable

 

 

-

 

 

 

(19,761 )(b)

 

 

(19,761 )

 

 

(24,369 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL CURRENT LIABILITIES

 

 

707,492

 

 

 

(168,711 )

 

 

538,781

 

 

 

664,429

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

707,492

 

 

 

(168,711 )

 

 

538,781

 

 

 

664,429

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET ASSETS (LIABILITIES)

 

£ 33,880

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIT:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Called Up Share Capital

 

 

140,961

 

 

 

(140,961 )(c)

 

 

-

 

 

 

-

 

Common Stock

 

 

-

 

 

 

961 (c)

 

 

961

 

 

 

1,185

 

Additional paid-in capital

 

 

-

 

 

 

140,000 (c)

 

 

140,000

 

 

 

172,649

 

Accumulated other comprehensive loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

21,456

 

Accumulated deficit

 

 

(107,081 )

 

 

(418,898 )(a)

 

 

(525,979 )

 

 

(670,099 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL STOCKHOLDERS' DEFICIT

 

 

33,880

 

 

 

(418,898 )

 

 

(385,018 )

 

 

(474,809 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

 

£ 741,372

 

 

£

587,609

 

 

£ 153,763

 

 

$ 189,620

 

__________

(a)

For reporting entities, U.S. GAAP for publicly held companies sets forth four requirements that must generally be met before revenue can be realized and earned: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services have been rendered; (3) the seller’s price to the buyer is fixed or determinable; and (4) collectability is reasonably assured. At the time of this filing, Decadhedron Net Sales (Turnover) includes income for research services with a related party, the collection of which has not been received and cannot be reasonable assured. Therefore, these sales (£424,200) have been excluded and the related foreign currency loss (£5,302) and the net change to the accumulated deficit of (£418,898).

(b)

For reporting entities, U.S. GAAP requires the disclosure of accounts receivable, prepaid expenses and other current assets, loans payable - related party and corporation tax payable to be reported seperately.

(c)

For reporting entities, U.S. GAAP requires the disclosure of common stock and additional paid-in capital to be reported seperately.

   

 

8